Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more
Therapeutic Advances in Neurological Disorders, 05/24/2012
Mayer MC et al. – The authors summarize key findings from experimental models and patient studies, discuss challenges in detecting anti–myelin oligodendrocyte glycoprotein (MOG) antibodies in patients and present recent approaches to identifying new autoantigens in multiple sclerosis (MS).



